embecta
94%
Employees say this is a great place to work
Company Overview
About The Company
embecta is a global company focused on improving the health and well-being of people living with diabetes. Our history in insulin injection dates to 1924 and the development of the world's first specialized insulin syringe. Following a spinoff from Becton, Dickinson and Company in 2022, embecta become an independent, publicly-traded company and we are the world’s leading producer of insulin injection devices, manufacturing approximately 8 billion pen needles and syringes annually for an estimated 30 million people in 100+ countries. We work to advance the standard of care in insulin delivery through community partnerships, innovative technology and comprehensive care resources. COMPANY SIZE
34
Industry
Health Care
HQ Location
Mississauga
Interested in a career at embecta, or just want to know more?
To discover what sets embecta apart and explore relevant career opportunities, take a look at their website.
Company Culture at embecta
The employee experience below at embecta, compared to a typical company.
Learn More94% of employees at embecta say it is a great place to work compared to 60% of employees at a typical company.
Source: Great Place to Work® 2021 Global Employee Engagement Study.
Life at embecta
CONNECT